[seopress_breadcrumbs]

Predicting the ROI of AI – Pitfalls to AI Adoption in the Enterprise (Part 3 of 3)

•

April 15, 2019

In the final installment of the "Pitfalls to AI Adoption" series, we talk about predicting the ROI of AI. There are a lot of misconceptions running rampant around the ability to gauge the return on investment of artificial intelligence. In this article, we talk about what can and can't be done when it comes to investing in artificial intelligence and predicting what the return might be.

How much will an AI project cost?
How long will the integration take before the software is ready to use?
How will it be able to be used to drive value?
Will it be able to do what you want?
D0 you know for sur...

[mrj_paywall] unauthorized access

Recommended from Emerj

Artificial Intelligence at Barclays – Two Use Cases

Barclays is a leading British universal bank with a diversified portfolio serving retail and wholesale customers globally. The bank employs over 100,000 people worldwide, reflecting its significant global footprint and scale. In its most recent financial results for Q1 2025, Barclays reported £7.7 billion as total income, up 11% year-on-year. Barclays’ approach to AI centers…

Riya Pahuja

•

June 30, 2025

Building AI Systems That Think Like Scientists in Life Sciences – with Annabel Romero of Deloitte

This interview analysis is sponsored by Deloitte and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page. Large language models have significantly advanced the field of genomics by enabling the prediction of genome-wide variant effects,…

Riya Pahuja

•

June 24, 2025

Inside Enterprise Strategies for Fighting First Party Fraud at Scale – with Leaders from Justt and Walmart

This article is sponsored by Justt and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page. Fraud and chargebacks present a massive and growing financial burden for merchants and financial institutions. According to Visa's Fall…

Riya Pahuja

•

June 23, 2025

Artificial Intelligence at CVS Health

As one of the largest healthcare companies in the United States, CVS Health generated $357.8 billion in revenue in 2023 and serves over 100 million people annually across its insurance, retail, and pharmacy operations. With such an expansive footprint, the company’s internal application of AI is critical not only to improve operational efficiency but also…

Emily Smith

•

June 20, 2025

How Leaders in Regulated Industries Are Scaling Enterprise AI – with Leaders from Searce, Blue Cross Blue Shield, US Bank, and Citi

This interview analysis is sponsored by Searce and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page. Regulated industries, such as healthcare and finance, face significant barriers to AI adoption—compliance constraints and legacy systems hinder…

Marilie Fouche

•

June 18, 2025

Artificial Intelligence at BMW

Headquartered in Munich and founded in 1916 in Germany, the BMW Group is a multinational vehicle manufacturer that manufactures vehicles in Germany, the United Kingdom, the United States, Brazil, Mexico, South Africa, India, and China. In the US alone, BMW brand sales totaled 87,615 vehicles in the first quarter of this year, which represents a…

Sharon Moran

•

June 16, 2025

AI for Drug Development and Portfolio Management – with Leaders from Intelligencia AI and Novartis

This interview analysis is sponsored by Intelligencia AI and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page. Rising costs, long development cycles, and uncertain success rates continue to challenge pharmaceutical R&D efficiency. According to…

Marilie Fouche

•

June 12, 2025

Building Better PCB Layouts with AI Driven Optimization – with Alain-Sam Cohen at InstaDeep

This interview analysis is sponsored by InstaDeep and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page. Printed circuit boards (PCBs) are the foundation of virtually every electronic device, from smartphones to spacecraft. Despite decades…

Marilie Fouche

•

June 11, 2025

Securing GenAI at Scale for Observability, Guardrails, and Risk – with Leaders from ActiveFence and Barclays

This article is sponsored by ActiveFence and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page. As generative AI systems enter mainstream enterprise workflows, the conversation around AI safety has shifted from theoretical concern to…

Marilie Fouche

•

June 6, 2025

AI Data Strategies for Life Sciences Agriculture and Materials Science – with Daniel Ferrante of Deloitte

This interview analysis is sponsored by Deloitte and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page. R&D teams across life sciences, agriculture, and materials science are under increasing pressure to deliver innovation — but…

Matthew DeMello

•

June 5, 2025

How Cloud Computing and AI are Shaping Life Sciences – with Pranav Joshi of Merck

Personalization and localization have become critical imperatives in the pharmaceutical industry. The shift from broad-spectrum therapies to precision medicine — rooted in pharmacogenomics and biomarker analysis — has demonstrated measurable improvements in treatment efficacy while reducing adverse drug reactions by up to 30%, according to a study by the Leiden University Medical Center known as …

Ashwin Telang

•

June 2, 2025

Scaling AI with Storage Efficiency – Emerj AI Leader Insight

This article is sponsored by Pure Storage and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.As enterprises race to implement AI, most hit a bottleneck that's hiding in plain sight: inefficient storage infrastructure. While…

Riya Pahuja

•

May 29, 2025

Search site

Search site

Predicting the ROI of AI – Pitfalls to AI Adoption in the Enterprise (Part 3 of 3)

Recommended from Emerj

Artificial Intelligence at Barclays – Two Use Cases

Building AI Systems That Think Like Scientists in Life Sciences – with Annabel Romero of Deloitte

Inside Enterprise Strategies for Fighting First Party Fraud at Scale – with Leaders from Justt and Walmart

Artificial Intelligence at CVS Health

How Leaders in Regulated Industries Are Scaling Enterprise AI – with Leaders from Searce, Blue Cross Blue Shield, US Bank, and Citi

Artificial Intelligence at BMW

AI for Drug Development and Portfolio Management – with Leaders from Intelligencia AI and Novartis

Building Better PCB Layouts with AI Driven Optimization – with Alain-Sam Cohen at InstaDeep

Securing GenAI at Scale for Observability, Guardrails, and Risk – with Leaders from ActiveFence and Barclays

AI Data Strategies for Life Sciences Agriculture and Materials Science – with Daniel Ferrante of Deloitte

How Cloud Computing and AI are Shaping Life Sciences – with Pranav Joshi of Merck

Scaling AI with Storage Efficiency – Emerj AI Leader Insight

Customize Your Experience

Predicting the ROI of AI – Pitfalls to AI Adoption in the Enterprise (Part 3 of 3)

Share article

Subscribe to updates

Recommended from Emerj

Artificial Intelligence at Barclays – Two Use Cases

Building AI Systems That Think Like Scientists in Life Sciences – with Annabel Romero of Deloitte

Inside Enterprise Strategies for Fighting First Party Fraud at Scale – with Leaders from Justt and Walmart

Artificial Intelligence at CVS Health

How Leaders in Regulated Industries Are Scaling Enterprise AI – with Leaders from Searce, Blue Cross Blue Shield, US Bank, and Citi

Artificial Intelligence at BMW

AI for Drug Development and Portfolio Management – with Leaders from Intelligencia AI and Novartis

Building Better PCB Layouts with AI Driven Optimization – with Alain-Sam Cohen at InstaDeep

Securing GenAI at Scale for Observability, Guardrails, and Risk – with Leaders from ActiveFence and Barclays

AI Data Strategies for Life Sciences Agriculture and Materials Science – with Daniel Ferrante of Deloitte

How Cloud Computing and AI are Shaping Life Sciences – with Pranav Joshi of Merck

Scaling AI with Storage Efficiency – Emerj AI Leader Insight

This Content is Exclusive to Emerj Plus Members

In-Depth Analysis

Exclusive AI Capabilities Matrix

Exclusive AI White Paper Library

Best Practices and executive guides

Register

Customize Your Experience